UCalgary VetMed Announcement
Ceapro Inc. Initiates Phase 1-2a Study Assessing Its Flagship Product Avenanthramides for Potential Applications in Inflammation Based Diseases
From Europe to Canada: Why are tech companies expanding to Alberta?
Revolutionizing Agriculture: The Crucial Role of Cryopreservation
Cracking the Code of Cellular Health: Dr. Vocadlo’s Pioneering Research
University of Alberta Assigns Full Suite of Patents to 48Hour Discovery as Revenue Exceeds $5 Million Triggering Key Milestone
Research Chair recieves $8 million over the next eight years to continue his work at the University of Alberta
Syantra Announces Liquid Biopsy Platform Breakthrough with Expanded Intellectual Property Portfolio; Partnership with Limmi to Accelerate AI-Powered RNA-Based Early Cancer Detection Liquid Biopsy Program
Alberta Virtual Care Coordinating Body (AVCCB)
Orano Med and 48Hour Discovery to Develop Innovative Peptide Receptor Radionuclide Therapy for Targeted Cancer Treatment
